Suppr超能文献

酮洛芬单次口服、肌内注射和直肠给药后以及重复口服给药后的药代动力学。

Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration.

作者信息

Ishizaki T, Sasaki T, Suganuma T, Horai Y, Chiba K, Watanabe M, Asuke W, Hoshi H

出版信息

Eur J Clin Pharmacol. 1980 Nov;18(5):407-14. doi: 10.1007/BF00636794.

Abstract

The pharmacokinetics of ketoprofen was studied in the same healthy subjects after single oral, intramuscular and rectal doses, and after repeated oral administration. No significant difference in the mean t1/2 (1.13-1.27 h) was observed after the different modes of administration. The mean [AUC] 0 infinity after rectal administration of a suppository showed the minimum significant difference (p < 0.05) from that after oral administration of the capsule. The apparent volume of distribution (Vd/F) was approximately 10-15% of body weight. The renal contribution (mean, 0.10-0.15 ml/min/kg) to the plasma clearance of free ketoprofen was assumed to be, at most, 8.3-12.9%. The projected cumulative excretion of total (free plus conjugated) ketoprofen via urine exceeded 63-75% of the dose, of which approximately 90% was ketoprofen glucuronide. A mean of 71-96% and 73-93% of the oral capsule was estimated to be systemically available after administration of the intramuscular preparation and rectal suppository, respectively. In four of seven subjects, CPK concentration was elevated after the intramuscular injection. The mean steady-state concentration of ketoprofen in plasma ranged from 0.43 to 5.62 microgram/ml after the final dose of a 50 mg q. i. d. regimen. The disposition data and plasma levels observed at steady-state were in agreement with those predicted from the single oral dose study. The accumulation ratio was 1.08 +/- 0.08. The results suggest that the rectal suppository can be recommended as an extravascular mode of administration of this drug.

摘要

在同一组健康受试者中,研究了酮洛芬单次口服、肌内注射和直肠给药后的药代动力学,以及多次口服给药后的药代动力学。不同给药方式后,平均半衰期(t1/2)(1.13 - 1.27小时)无显著差异。直肠给予栓剂后的平均[AUC]0至无穷大与口服胶囊后的相比,差异最小且具有统计学意义(p < 0.05)。表观分布容积(Vd/F)约为体重的10 - 15%。游离酮洛芬经肾清除对血浆清除率的贡献(平均值为0.10 - 0.15 ml/min/kg)最多为8.3 - 12.9%。预计经尿液排泄的总(游离加结合)酮洛芬累积量超过剂量的63 - 75%,其中约90%为酮洛芬葡糖醛酸苷。估计肌内注射制剂和直肠栓剂给药后,口服胶囊分别有71 - 96%和73 - 93%的药物可被全身利用。7名受试者中有4名在肌内注射后肌酸磷酸激酶(CPK)浓度升高。在50 mg每日4次的给药方案最后一剂后,血浆中酮洛芬的平均稳态浓度范围为0.43至5.62微克/毫升。稳态时观察到的处置数据和血浆水平与单次口服剂量研究预测的数据一致。蓄积比为1.08±0.08。结果表明,直肠栓剂可作为该药物的一种血管外给药方式推荐使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验